Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1987
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 2
1991 1
1992 1
1993 1
1994 1
1995 1
1996 5
2000 2
2001 3
2003 1
2004 1
2005 5
2006 1
2007 1
2008 1
2009 1
2010 1
2011 3
2012 7
2013 5
2014 4
2015 3
2016 6
2017 1
2018 3
2019 6
2020 5
2021 2
2022 4
2023 2
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP).
Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S; Tysabri Observational Program (TOP) Investigators. Butzkueven H, et al. J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):660-668. doi: 10.1136/jnnp-2019-322326. Epub 2020 Mar 31. J Neurol Neurosurg Psychiatry. 2020. PMID: 32234967 Free PMC article.
[Treatment of multiple sclerosis].
Midgard R. Midgard R. Tidsskr Nor Laegeforen. 2001 Aug 20;121(19):2254. Tidsskr Nor Laegeforen. 2001. PMID: 11571873 Free article. Norwegian. No abstract available.
Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
Filippini G, Brusaferri F, Sibley WA, Citterio A, Ciucci G, Midgard R, Candelise L. Filippini G, et al. Among authors: midgard r. Cochrane Database Syst Rev. 2000;2000(4):CD001331. doi: 10.1002/14651858.CD001331. Cochrane Database Syst Rev. 2000. PMID: 11034713 Free PMC article. Review.
Cancer related mortality in multiple sclerosis. A population based cohort study.
Grytten N, Myhr KM, Celius EG, Benjaminsen E, Midgard R, Vatne A, Aarseth JH, Mannseth J, Torkildsen Ø. Grytten N, et al. Among authors: midgard r. Mult Scler Relat Disord. 2023 Jan;69:104417. doi: 10.1016/j.msard.2022.104417. Epub 2022 Nov 17. Mult Scler Relat Disord. 2023. PMID: 36423459 Free article.
Factors influencing employment after minor stroke and NSTEMI.
Morsund ÅH, Ellekjær H, Gramstad A, Reiestad MT, Midgard R, Sando SB, Jonsbu E, Næss H. Morsund ÅH, et al. Among authors: midgard r. J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105036. doi: 10.1016/j.jstrokecerebrovasdis.2020.105036. Epub 2020 Jun 23. J Stroke Cerebrovasc Dis. 2020. PMID: 32807448
Body mass index influence interferon-beta treatment response in multiple sclerosis.
Kvistad SS, Myhr KM, Holmøy T, Šaltytė Benth J, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Michelsen AE, Aukrust P, Ueland T, Sagen JV, Torkildsen Ø. Kvistad SS, et al. Among authors: midgard r. J Neuroimmunol. 2015 Nov 15;288:92-7. doi: 10.1016/j.jneuroim.2015.09.008. Epub 2015 Sep 26. J Neuroimmunol. 2015. PMID: 26531700 Clinical Trial.
WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
Holmøy T, Esbensen QY, Torkildsen Ø, Wergeland S, Bjerve KS, Beiske AG, Midgard R, Šaltytė-Benth J, Hovdal H, Myhr KM. Holmøy T, et al. Among authors: midgard r. Acta Neurol Scand. 2016 Apr;133(4):309-12. doi: 10.1111/ane.12448. Epub 2015 Jun 2. Acta Neurol Scand. 2016. PMID: 26037530
74 results